Samantha Ferrari

Vemurafenib plus Rituximab in Refractory or Relapsed Hairy-Cell Leukemia

Enrico Tiacci, Edoardo Simonetti, Monia Capponi et al. · New England Journal of Medicine · 2021 · 122 citations

Medicine, Oncology, Pharmacotherapy +13

Bortezomib induction, reduced-intensity transplantation, and lenalidomide consolidation-maintenance for myeloma: updated results

Francesca Gay, Valeria Magarotto, Claudia Crippa et al. · Blood · 2013 · 82 citations · Full text

Medicine, Hematology, Pharmacotherapy +16

The e13a2 BCR‐ABL transcript negatively affects sustained deep molecular response and the achievement of treatment‐free remission in patients with chronic myeloid leukemia who receive tyrosine kinase inhibitors

Mariella D’Adda, Mirko Farina, Francesca Schieppati et al. · Cancer · 2019 · 64 citations · Full text

Medicine, Oncology, Pharmacology +14

Transplant eligibility in elderly multiple myeloma patients: Prospective external validation of the international myeloma working group frailty score and comparison with clinical judgment and other comorbidity scores in unselected patients aged 65‐75 years

Angelo Belotti, Rossella Ribolla, Valeria Cancelli et al. · American Journal of Hematology · 2020 · 39 citations · Full text

Medicine, Hematology, Oncology +15

Predictive role of diffusion‐weighted whole‐body MRI (DW‐MRI) imaging response according to MY‐RADS criteria after autologous stem cell transplantation in patients with multiple myeloma and combined evaluation with MRD assessment by flow cytometry

Angelo Belotti, Rossella Ribolla, Valeria Cancelli et al. · Cancer Medicine · 2021 · 39 citations · Full text

Medicine, Hematology, Radiology +17